Corrigendum to “Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity” [Cancer Lett., 548, (1 November 2022)]
Titel:
Corrigendum to “Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity” [Cancer Lett., 548, (1 November 2022)]
Auteur:
Xu, Mingjing Liu, Yue Wan, Ho Lee Wong, Alissa M. Ding, Xiaofan You, Wenxing Lo, Wing Sze Ng, Kelvin K-C Wong, Nathalie